Peritoneal mesothelioma presenting as an acute surgical abdomen due to jejunal perforation

November 1, 2007 | Comments Off on Peritoneal mesothelioma presenting as an acute surgical abdomen due to jejunal perforation

Journal of Digestive Diseases. 2007 Nov;8(4):216-21. [Link] Salemis NS, Tsiambas E, Gourgiotis S, Mela A, Karameris A, Tsohataridis E. 2nd Department of Surgery, 417 Army Veterans General Hospital NIMTS, Athens,…

Real surgical morbidity and mortality after extrapleural pneumonectomy

October 31, 2007 | Comments Off on Real surgical morbidity and mortality after extrapleural pneumonectomy

Chirurgia Italiana. 2007 Jul-Aug;59(4):453-60. [Link] Pagan V, Fontana P, Zaccaria A, Lo Giudice F, Ferronato A, Salvi R, Lovadina S. Thoracic Surgery Unit, Umberto I General Hospital, Venezia-Mestre. Abstract As…

Mesothelioma in vehicle mechanics: is the risk different for Australians?

October 30, 2007 | Comments Off on Mesothelioma in vehicle mechanics: is the risk different for Australians?

Occupational Medicine. 2007 Dec;57(8):581-9. Epub 2007 Oct 27. [Link] Kelsh MA, Craven VA, Teta MJ, Mowat FS, Goodman M. Exponent, Inc., 149 Commonwealth Drive, Menlo Park, CA 94025, USA. Abstract…

French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins

October 27, 2007 | Comments Off on French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins

Cancer/Radiothérapie. 2007 Nov;11(6-7):331-337. Epub 2007 Oct 24. [Link] Kantor G, Mahé MA, Giraud P; et les contributeurs des protocoles, Alapetite C, Durdux C, Fourquet A, Gardner M, Le Prisé E,…

Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial—An Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)

October 27, 2007 | Comments Off on Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial—An Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)

The Oncologist. 2007 Oct;12(10):1215-24. [Link] Fasola G, Belvedere O, Aita M, Zanin T, Follador A, Cassetti P, Meduri S, De Pangher V, Pignata G, Rosolen V, Barbone F, Grossi F.…

Asbestos exposure, legislation and diseases in the Czech Republic

October 26, 2007 | Comments Off on Asbestos exposure, legislation and diseases in the Czech Republic

Central European Journal of Public Health. 2007 Sep;15(3):99-102. [Link] Pelclová D, Fenclová Z, Urban P. Department of Occupational Medicine, Charles University, Prague. daniela.pelclova@lf1.cuni.cz Abstract Asbestos manufacturing has been banned in…

Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM)

October 24, 2007 | Comments Off on Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM)

Cancer Letters. 2007 Dec 18;258(2):215-22. Epub 2007 Oct 18. [Link] Nasreen N, Mohammed KA, Lai Y, Antony VB. Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of…

Immunohistochemical Detection of XIAP in Mesothelium and Mesothelial Lesions

October 24, 2007 | Comments Off on Immunohistochemical Detection of XIAP in Mesothelium and Mesothelial Lesions

American Journal of Clinical Pathology. 2007 Nov;128(5):783-7. [Link] Wu M, Sun Y, Li G, Desman G, Wang B, Gil J, Burstein DE. Department of Pathology, Mount Sinai School of Medicine,…

Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome

October 24, 2007 | Comments Off on Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome

Lung. 2007 Nov-Dec;185(6):349-54. Epub 2007 Oct 19. [Link] Yildirim H, Metintas M, Ak G, Erginel S, Alatas F, Kurt E, Metintas S, Ucgun I. Department of Chest Diseases, Medical Faculty,…

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

October 24, 2007 | Comments Off on Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Molecular Cancer. 2007 Oct 22;6(1):66 [Epub ahead of print]. [Link] Belyanskaya LL, Marti TM, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, Stahel RA. Abstract Background: The incidence of malignant pleural mesothelioma…

Categories